Please login to the form below

Not currently logged in
Email:
Password:

Harvard Medical School

This page shows the latest Harvard Medical School news and features for those working in and with pharma, biotech and healthcare.

Researchers use AI to identify drugs that could be repurposed for Alzheimer’s

Researchers use AI to identify drugs that could be repurposed for Alzheimer’s

Researchers from Harvard Medical School and Massachussetts General Hospital have revealed which drugs could be potentially repurposed as possible treatments for Alzheimer’s disease using artificial intelligence (AI). ... substantial resources, making

Latest news

More from news
Approximately 1 fully matching, plus 37 partially matching documents found.

Latest Intelligence

  • Staying ahead in the era of precision medicine Staying ahead in the era of precision medicine

    As expressed by Professor George Demetri of the Dana- Farber Cancer Institute and Harvard Medical School: “There’s a remarkable need for better communications, both about and around the issues in ... They have to keep up. Communicating this is almost

  • Using social data to see patients more clearly Using social data to see patients more clearly

    To answer this question, we partnered with researchers at Brigham and Women's Hospital, Harvard Medical School, and Partners HealthCare System to conduct a pilot study on the differences and similarities ... These posts are collected using a patented

  • Astellas: Ten years young Astellas: Ten years young

    Chief medical officer and president of global development Sef Kurstjens explains: “Some of the diversity we get is through one effect - that we have a global portfolio, as well as a ... But partnerships, as is so often the case, will be key, and it's

  • Counting down to the EFPIA Disclosure Code Counting down to the EFPIA Disclosure Code

    It sent dollar sign shockwaves across the US and caused a dip in faith in the medical profession and pharmaceutical companies. ... A report from Harvard Medical School found that 88% of $76.7m paid by the pharmaceutical industry to Massachusetts

More from intelligence
Approximately 0 fully matching, plus 4 partially matching documents found.

Latest appointments

  • Health comms agency emotive hires new cell and gene therapy leader Health comms agency emotive hires new cell and gene therapy leader

    information is of pivotal importance for the companies, the central authorities, and also for medical specialists, scientists and patients.". ... She completed her post-doctoral training at Harvard Medical School and has spent over eight years working

  • New hires at Nanoform, Leo Pharma and Calliditas New hires at Nanoform, Leo Pharma and Calliditas

    Leo Pharma boosts Translational Medicine team. Adam Raff will soon join dermatology-focused Leo Pharma, heading up the company’s new Translational Medicine Unit as director and medical advisor. ... Raff currently works as a dermatologist at the

  • Big Health expands executive team Big Health expands executive team

    Meanwhile, Dr Carl joins Big Health as medical director, bringing nearly 10 years of experience in clinical research and treatment of mental health conditions in adults. ... She has held research positions at Harvard Medical School, UCSF Medical Center,

  • Shire’s Dr Armin Reininger moves to Sobi Shire’s Dr Armin Reininger moves to Sobi

    Stockholm-based Sobi has appointed Dr Armin Reininger as a senior vice president and head of global medical and scientific affairs. ... Prior to this, Dr Reininger held several academic research and clinical positions at the Ludwig Maximillian University

  • Pfizer appoints chief scientific officer Pfizer appoints chief scientific officer

    Dr Isacson joins the pharma giant from Harvard Medical School, where he is a professor of neurology, and will continue to serve in an educational role while at Pfizer. ... Having first joined Harvard in 1989, Dr Isacson's work in neurogenerative disorders

More from appointments
Approximately 0 fully matching, plus 9 partially matching documents found.

Latest from PMHub

  • Three amazing women at emotive talk about what they love about medical communications

    Dr Silvana Bardelli,  Senior Medical Writer, has a PhD in human molecular genetics and completed her post-doctoral research at Harvard Medical School. ... emotive is an award-winning healthcare communications agency working with leading global life

  • emotive. grows medical writing capacity

    as a senior medical writer.  . Silvana completed her post-doctoral training at Harvard Medical School, and has spent over 7 years working across a broad variety of research, regulatory, quality assurance, ... and medical writing roles at scientific

  • NEWS from Gower Publishing

    A "must read" for anyone involved with moving their organization toward integrated care.’Joel S.Weissman, Harvard Medical School, USA.

More from PMHub
Approximately 0 fully matching, plus 3 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Hanover Communications

Healthcare is evolving rapidly. To stand out from the crowd requires a potent combination of rich insight, innovative ideas and...

Latest intelligence

InSite Events™ National Pharma Meeting: A Customer Story
How our client leveraged Impetus Digital’s white-glove service, 360° coverage and care, and award-winning InSite Events™ platform to successfully transfer their annual national meeting online....
Fear or encouragement, which is best to drive behaviour change?
The communications industry depends on fear of the perceived loss of something, in order to create the hope found in a product benefit. But, if if left too long unchecked,...
The unheard, unseen, and uncorrected effects of COVID-19
The disproportionate effects of the pandemic have been highlighted amongst ethnic minorities, so is it likely that ethnic minorities will be more worried about participating? And could this exacerbate inequalities...

Infographics